Valine
CAS 72-18-4
Valine (CAS 72-18-4) is a Phase 2 pharmaceutical compound with 1 bioactivity target and 2 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | MIC | 6130.7692307692305 nM | 13 | - |
| - | IC50 | 68000 nM | 1 | - |
| Large neutral amino acids transporter small subunit 1 Transporter |
IC50 | 4.17 | - | Homo sapiens |
Adverse Event Associations
DrugCentral / FAERS disproportionality signal rows matched to this compound.
| Reaction PT | Drug AE | LLR | MedDRA |
|---|---|---|---|
| Foetal growth restriction | 15 | 64.586 | 10070531 |
| Compartment syndrome | 10 | 49.22 | 10010121 |
Association rows are source-linked signal records, not incidence rates or clinical causality claims.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| Valine | 11115 | SU | MTHSPL |
| VALINE | 11115 | SU | MTHSPL |
| valine | 11115 | IN | RXNORM |
| L-valine | 11115 | SY | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Valine used for in pharmaceutical contexts?
Valine (CAS 72-18-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Valine?
Valine has 2 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Foetal growth restriction, Compartment syndrome. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Valine also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for L-Valine with EU status "permitted".
What clinical phase is Valine in?
Valine is rendered with ChEMBL max phase 2.
What bioactivity targets are documented for Valine?
Valine has 3 bioactivity rows in this page query. Rendered target entries include Large neutral amino acids transporter small subunit 1.